Based on previous research and promising clinical data 20,22 , we have designed a single chimeric peptide intended to target GLP-1R, Y1-R, and Y2-R-mediated pathways simultaneously
They deliver substantial, sustained weight loss by curbing appetite and overall food intake, which can improve blood pressure, lipids, sleep apnea risk, mobility, and quality of life
Our comprehensive weight health platform flexes to align with your strategy supporting your population, your benefits objectives, and what comes next
"Arava (leflunomide) dosing, indications, interactions, adverse effects, and more"
GLP-1 receptor agonists stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning they only trigger insulin release when blood glucose levels are elevated
Several pharmaceutical companies have patient assistance programs or coupons available for eligible individuals struggling to afford the medication